FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application to authorize a generic clopidogrel bisulfate product from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL BISULFATE)